Did you know that in the US alone there are 117 medications approved for clinical depression? That hundreds more are approved for other psychiatric and behavioral health disorders? That alternative treatments like neuromodulation work in certain subgroups, but that responders are difficult to identify until after an expensive intervention is approved?
It’s no wonder that leading psychiatrists, let alone primary care, can sometime take years to get patients on the right treatments.
At Altimate Health, we combine unique insights from both cutting edge neuroscience as well as advanced computational and data analysis techniques to identify not only patients at risk for behavioral health disorders, but also the course of treatment most likely to be effective for each patient. Saving not just the cost of ineffective treatments and co-morbidities, but the human suffering associated with misdiagnosed or incorrectly treated conditions.
[Updated November 5, 2019]